Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119123020> ?p ?o ?g. }
- W3119123020 endingPage "4217" @default.
- W3119123020 startingPage "4205" @default.
- W3119123020 abstract "Abstract Objectives To investigate whether abnormal BMI is associated with adverse health-related quality of life (HRQoL) outcome, including severe fatigue, after 52 weeks of standard therapy plus belimumab or placebo in patients with SLE. Methods We analysed data from the BLISS-52 (NCT00424476) and BLISS-76 (NCT00410384) trials (n = 1684). Adverse HRQoL was defined as SF-36 scores ≤ the fifth percentile in age- and sex-matched US population-based subjects, and FACIT-F scores <30. We compared BMI groups using the Pearson’s χ2 test, and assessed independence with multivariable logistic regression analysis. Results Overweight (BMI ≥25 kg/m2) and obese (BMI ≥30 kg/m2) patients showed increased likelihood to exhibit adverse SF-36 physical component summary (OR: 1.8; 95% CI: 1.4, 2.3; P <0.001 and OR: 2.4; 95% CI: 1.8, 3.2; P <0.001, respectively) and FACIT-F (OR: 1.3; 95% CI: 1.1, 1.6; P = 0.010 and OR: 1.5; 95% CI: 1.2, 2.0; P = 0.002, respectively) scores at week 52. Underweight was associated with adverse SF-36 mental component summary scores, also after adjustment for sex, ancestry, age, disease duration, disease activity, organ damage and prednisone dose during the study period (OR: 2.1; 95% CI: 1.2, 3.6; P = 0.007). Addition of belimumab to standard therapy independently protected against adverse SF-36 general health (OR: 0.8; 95% CI: 0.6, 1.0; P = 0.025) and FACIT-F < 30 (OR: 0.8; 95% CI: 0.6, 1.0; P = 0.018). Conclusion Overweight and obesity contributed to adverse physical and mental HRQoL outcomes after therapeutic intervention in SLE patients, and underweight contributed to adverse mental HRQoL outcome. A protective effect of belimumab against adverse general health and severe fatigue was implicated." @default.
- W3119123020 created "2021-01-18" @default.
- W3119123020 creator A5002838445 @default.
- W3119123020 creator A5003390928 @default.
- W3119123020 creator A5006834335 @default.
- W3119123020 creator A5030936104 @default.
- W3119123020 creator A5036063848 @default.
- W3119123020 creator A5046864092 @default.
- W3119123020 creator A5059049923 @default.
- W3119123020 creator A5066450516 @default.
- W3119123020 creator A5086543859 @default.
- W3119123020 creator A5088107760 @default.
- W3119123020 date "2021-01-06" @default.
- W3119123020 modified "2023-09-30" @default.
- W3119123020 title "Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week therapy in patients with SLE" @default.
- W3119123020 cites W2001012319 @default.
- W3119123020 cites W2020246748 @default.
- W3119123020 cites W2030809779 @default.
- W3119123020 cites W2042719511 @default.
- W3119123020 cites W2070527591 @default.
- W3119123020 cites W2091265892 @default.
- W3119123020 cites W2092815162 @default.
- W3119123020 cites W2107216509 @default.
- W3119123020 cites W2108905161 @default.
- W3119123020 cites W2119763916 @default.
- W3119123020 cites W2126478084 @default.
- W3119123020 cites W2127134739 @default.
- W3119123020 cites W2131457901 @default.
- W3119123020 cites W2133406473 @default.
- W3119123020 cites W2136149088 @default.
- W3119123020 cites W2137638342 @default.
- W3119123020 cites W2139983741 @default.
- W3119123020 cites W2141455950 @default.
- W3119123020 cites W2149564130 @default.
- W3119123020 cites W2154196385 @default.
- W3119123020 cites W2165544559 @default.
- W3119123020 cites W2255510115 @default.
- W3119123020 cites W2297962324 @default.
- W3119123020 cites W2493857620 @default.
- W3119123020 cites W2587800318 @default.
- W3119123020 cites W2734675357 @default.
- W3119123020 cites W2761568588 @default.
- W3119123020 cites W2884398163 @default.
- W3119123020 cites W2898107909 @default.
- W3119123020 cites W2910380754 @default.
- W3119123020 cites W2958939935 @default.
- W3119123020 cites W3012070848 @default.
- W3119123020 cites W4292806894 @default.
- W3119123020 doi "https://doi.org/10.1093/rheumatology/keaa909" @default.
- W3119123020 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8410008" @default.
- W3119123020 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33404659" @default.
- W3119123020 hasPublicationYear "2021" @default.
- W3119123020 type Work @default.
- W3119123020 sameAs 3119123020 @default.
- W3119123020 citedByCount "9" @default.
- W3119123020 countsByYear W31191230202021 @default.
- W3119123020 countsByYear W31191230202022 @default.
- W3119123020 countsByYear W31191230202023 @default.
- W3119123020 crossrefType "journal-article" @default.
- W3119123020 hasAuthorship W3119123020A5002838445 @default.
- W3119123020 hasAuthorship W3119123020A5003390928 @default.
- W3119123020 hasAuthorship W3119123020A5006834335 @default.
- W3119123020 hasAuthorship W3119123020A5030936104 @default.
- W3119123020 hasAuthorship W3119123020A5036063848 @default.
- W3119123020 hasAuthorship W3119123020A5046864092 @default.
- W3119123020 hasAuthorship W3119123020A5059049923 @default.
- W3119123020 hasAuthorship W3119123020A5066450516 @default.
- W3119123020 hasAuthorship W3119123020A5086543859 @default.
- W3119123020 hasAuthorship W3119123020A5088107760 @default.
- W3119123020 hasBestOaLocation W31191230201 @default.
- W3119123020 hasConcept C126322002 @default.
- W3119123020 hasConcept C142724271 @default.
- W3119123020 hasConcept C156957248 @default.
- W3119123020 hasConcept C159110408 @default.
- W3119123020 hasConcept C197934379 @default.
- W3119123020 hasConcept C204787440 @default.
- W3119123020 hasConcept C27081682 @default.
- W3119123020 hasConcept C2779951463 @default.
- W3119123020 hasConcept C2780221984 @default.
- W3119123020 hasConcept C2780586474 @default.
- W3119123020 hasConcept C2781121325 @default.
- W3119123020 hasConcept C2908647359 @default.
- W3119123020 hasConcept C71924100 @default.
- W3119123020 hasConcept C99454951 @default.
- W3119123020 hasConceptScore W3119123020C126322002 @default.
- W3119123020 hasConceptScore W3119123020C142724271 @default.
- W3119123020 hasConceptScore W3119123020C156957248 @default.
- W3119123020 hasConceptScore W3119123020C159110408 @default.
- W3119123020 hasConceptScore W3119123020C197934379 @default.
- W3119123020 hasConceptScore W3119123020C204787440 @default.
- W3119123020 hasConceptScore W3119123020C27081682 @default.
- W3119123020 hasConceptScore W3119123020C2779951463 @default.
- W3119123020 hasConceptScore W3119123020C2780221984 @default.
- W3119123020 hasConceptScore W3119123020C2780586474 @default.
- W3119123020 hasConceptScore W3119123020C2781121325 @default.
- W3119123020 hasConceptScore W3119123020C2908647359 @default.
- W3119123020 hasConceptScore W3119123020C71924100 @default.
- W3119123020 hasConceptScore W3119123020C99454951 @default.